A detailed history of Aster Capital Management (Difc) LTD transactions in Silverback Therapeutics, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 608 shares of SBTX stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
608
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

BUY
N/A
608 New
608 $6.41 Million

Others Institutions Holding SBTX

About Silverback Therapeutics, Inc.


  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Aster Capital Management (Difc) LTD Portfolio

Follow Aster Capital Management (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aster Capital Management (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aster Capital Management (Difc) LTD with notifications on news.